Save the date: Coalition Connection: COVID-19 on 4 February
06:30am PST/ 09:30am EST/ 02:30pm GMT/ 03:30pm CET
On 4th February 2021, the Global Cancer Coalitions Network...
First Coalition Connection event sees publication of report showing devastating impact of COVID-19 on cancer organisations
On 4th February 2021, the Global Cancer Coalitions Network...
Save the date: Coalition Connection: COVID-19 on 4 February
06:30am PST/ 09:30am EST/ 02:30pm GMT/ 03:30pm CET
On 4th February 2021, the Global Cancer Coalition Network...
Research published in JCI Insight identified systemic inflammation as a possible resistance mechanism to a CD40–based chemoimmunotherapy in patients with advanced pancreatic cancer.1According to...
A number of facility-level characteristics were associated with the use of low-value breast cancer procedures, and interfacility variation presented an opportunity for formal de-implementation...
Chimeric antigen receptor (CAR) T-cell therapy with idecabtagene vicleucel (ide-cel) induced responses in almost 75% of patients with multiple myeloma following relpase on multiple...
